{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Essential oil", "Geranium oil", "MPTP model", "Neuroinflammation", "Parkinson\u2019s disease", "Pelargonium graveolens"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37819493", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1007/s11130-023-01112-3"], "Journal": {"ISSN": "1573-9104", "JournalIssue": {"Volume": "78", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Plant foods for human nutrition (Dordrecht, Netherlands)", "ISOAbbreviation": "Plant Foods Hum Nutr"}, "ArticleTitle": "Therapeutic Effects of Geranium Oil in MPTP-Induced Parkinsonian Mouse Model.", "Pagination": {"StartPage": "768", "EndPage": "775", "MedlinePgn": "768-775"}, "Abstract": {"AbstractText": ["Parkinson's disease (PD) is an incurable neurodegenerative disease characterized by motor and non-motor disabilities resulting from neuronal cell death in the substantia nigra and striatum. Microglial activation and oxidative stress are two of the primary mechanisms driving that neuronal death. Here, we evaluated the effects of geranium oil on 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) mouse model for PD, on microglial activation, and oxidative stress. We demonstrate that oral treatment with geranium oil improved motor performance in this model. The therapeutic effects of geranium oil were observed as a significant increase in rotarod latency and distance among the mice treated with geranium oil, as compared to vehicle-treated MPTP mice. Geranium oil also prevented dopaminergic neuron death in the substantia nigra of the treated mice. These therapeutic effects can be partially attributed to the antioxidant and anti-inflammatory properties of geranium oil, which were observed as attenuated accumulation of reactive oxygen species and inhibition of the secretion of proinflammatory cytokines from geranium oil-treated activated microglial cells. A repeated-dose oral toxicity study showed that geranium oil is not toxic to mice. In light of that finding and since geranium oil is defined by the FDA as generally recognized as safe (GRAS), we do not foresee any toxicity problems in the future and suggest that geranium oil may be a safe and effective oral treatment for PD. Since the MPTP model is only one of the preclinical models for PD, further studies are needed to confirm that geranium oil can be used to prevent or treat PD."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Sciences, Agricultural Research Organization, The Volcani Center, P.O. Box 15159, Rishon LeZion, 7505101, Israel."}], "LastName": "Telerman", "ForeName": "Alona", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Unit, Newe Ya'ar Research Center, Agricultural Research Organization, Ramat Yishay, Israel."}], "LastName": "Ravid", "ForeName": "Uzi", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Unit, Newe Ya'ar Research Center, Agricultural Research Organization, Ramat Yishay, Israel."}], "LastName": "Dudai", "ForeName": "Nativ", "Initials": "N"}, {"Identifier": ["0000-0003-2148-5994"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Sciences, Agricultural Research Organization, The Volcani Center, P.O. Box 15159, Rishon LeZion, 7505101, Israel. aelmann@volcani.agri.gov.il."}], "LastName": "Elmann", "ForeName": "Anat", "Initials": "A"}], "GrantList": [{"GrantID": "421-0135-09", "Agency": "Chief Scientist of the Ministry of Agriculture", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Plant Foods Hum Nutr", "NlmUniqueID": "8803554", "ISSNLinking": "0921-9668"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Geranium"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "Substantia Nigra"}, {"QualifierName": [], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36:1\u201312. https://doi.org/10.1016/j.cger.2019.08.002", "ArticleIdList": ["10.1016/j.cger.2019.08.002", "31733690"]}, {"Citation": "Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T (2021) Progress towards therapies for disease modification in Parkinson\u2019s disease. Lancet Neurol 20:559\u2013572. https://doi.org/10.1016/S1474-4422(21)00061-2", "ArticleIdList": ["10.1016/S1474-4422(21)00061-2", "34146514"]}, {"Citation": "Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Miliukhina IV, Bernadotte A (2018) Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-alpha levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol 327:77\u201382. https://doi.org/10.1016/j.cellimm.2018.02.011", "ArticleIdList": ["10.1016/j.cellimm.2018.02.011", "29478949"]}, {"Citation": "Leal MC, Casabona JC, Puntel M, Pitossi FJ (2013) Interleukin-1beta and tumor necrosis factor-alpha: reliable targets for protective therapies in Parkinson\u2019s disease? Front Cell Neurosci 7:53. https://doi.org/10.3389/fncel.2013.00053", "ArticleIdList": ["10.3389/fncel.2013.00053", "23641196", "3638129"]}, {"Citation": "More SV, Kumar H, Kim IS, Song SY, Choi DK (2013) Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mediators Inflamm 2013:952375. https://doi.org/10.1155/2013/952375", "ArticleIdList": ["10.1155/2013/952375", "23935251", "3712244"]}, {"Citation": "Pajares M, A IR, Manda G, Bosca L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease mechanisms and therapeutic implications. Cells 9. https://doi.org/10.3390/cells9071687"}, {"Citation": "Sanchez-Guajardo V, Tentillier N, Romero-Ramos M (2015) The relation between alpha-synuclein and microglia in Parkinson\u2019s disease: recent developments. Neuroscience 302:47\u201358. https://doi.org/10.1016/j.neuroscience.2015.02.008", "ArticleIdList": ["10.1016/j.neuroscience.2015.02.008", "25684748"]}, {"Citation": "Vesely B, Dufek M, Thon V, Brozman M, Kiralova S, Halaszova T, Koritakova E, Rektor I (2018) Interleukin 6 and complement serum level study in Parkinson\u2019s disease. J Neural Transm (Vienna) 125:885\u2013881. https://doi.org/10.1007/s00702-018-1857-5", "ArticleIdList": ["10.1007/s00702-018-1857-5"]}, {"Citation": "Zhang QS, Heng Y, Yuan YH, Chen NH (2017) Pathological alpha-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation. Toxicol Lett 265:30\u201337. https://doi.org/10.1016/j.toxlet.2016.11.002", "ArticleIdList": ["10.1016/j.toxlet.2016.11.002", "27865851"]}, {"Citation": "Weng M, Xie X, Liu C, Lim KL, Zhang CW, Li L (2018) The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson\u2019s Disease. Parkinsons Dis 2018:9163040. https://doi.org/10.1155/2018/9163040", "ArticleIdList": ["10.1155/2018/9163040", "30245802", "6139203"]}, {"Citation": "Puspita L, Chung SY, Shim JW (2017) Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 10:53. https://doi.org/10.1186/s13041-017-0340-9", "ArticleIdList": ["10.1186/s13041-017-0340-9", "29183391", "5706368"]}, {"Citation": "Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, Singh SP (2014) Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res 39:2527\u20132536. https://doi.org/10.1007/s11064-014-1443-7", "ArticleIdList": ["10.1007/s11064-014-1443-7", "25403619"]}, {"Citation": "Yadav SK, Rai SN, Singh SP (2017) Mucuna pruriens reduces inducible nitric oxide synthase expression in parkinsonian mice model. J Chem Neuroanat 80:1\u201310. https://doi.org/10.1016/j.jchemneu.2016.11.00", "ArticleIdList": ["10.1016/j.jchemneu.2016.11.00", "27919828"]}, {"Citation": "Rai SN, Yadav SK, Singh D, Singh SP (2016) Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced parkinsonian mouse model. J Chem Neuroanat 71:41\u201349. https://doi.org/10.1016/j.jchemneu.2015.12.002", "ArticleIdList": ["10.1016/j.jchemneu.2015.12.002", "26686287"]}, {"Citation": "Ramsey JT, Shropshire BC, Nagy TR, Chambers KD, Li Y, Korach KS (2020) Essential oils and health. Yale J Biol Med 93:291\u2013305", "ArticleIdList": ["32607090", "7309671"]}, {"Citation": "Javed H, Nagoor Meeran MF, Azimullah S, Adem A, Sadek B, Ojha SK (2018) Plant extracts and phytochemicals targeting alpha-synuclein aggregation in Parkinson\u2019s Disease Models. Front Pharmacol 9:1555. https://doi.org/10.3389/fphar.2018.01555", "ArticleIdList": ["10.3389/fphar.2018.01555", "30941047"]}, {"Citation": "Shahpiri Z, Bahramsoltani R, Hosein Farzaei M, Farzaei F, Rahimi R (2016) Phytochemicals as future drugs for Parkinson\u2019s disease: a comprehensive review. Rev Neurosci 27:651\u2013668. https://doi.org/10.1515/revneuro-2016-0004", "ArticleIdList": ["10.1515/revneuro-2016-0004", "27124673"]}, {"Citation": "Williamson EM (2001) Synergy and other interactions in phytomedicines. Phytomedicine 8:401\u2013409", "ArticleIdList": ["10.1078/0944-7113-00060", "11695885"]}, {"Citation": "Fekri N, El Amir D, Owis A, AbouZid S (2021) Studies on essential oil from rose-scented geranium, Pelargonium graveolens L\u2019Herit. (Geraniaceae). Nat Prod Res 35:2593\u20132597. https://doi.org/10.1080/14786419.2019.1682581", "ArticleIdList": ["10.1080/14786419.2019.1682581", "31679416"]}, {"Citation": "Elmann A, Mordechay S, Rindner M, Ravid U (2010) Anti-neuroinflammatory effects of geranium oil in microglial cells. J Funct Foods 2:17\u201322. https://doi.org/10.1016/j.jff.2009.12.001", "ArticleIdList": ["10.1016/j.jff.2009.12.001"]}, {"Citation": "Lis-Balchin M (2002) Geranium and pelargonium. Taylor & Francis Inc, London and Ney York", "ArticleIdList": ["10.1201/9780203216538"]}, {"Citation": "Abe S, Maruyama N, Hayama K, Inouye S, Oshima H, Yamaguchi H (2004) Suppression of neutrophil recruitment in mice by geranium essential oil. Mediators Inflamm 2004 13:21\u201324. https://doi.org/10.1080/09629350410001664798", "ArticleIdList": ["10.1080/09629350410001664798"]}, {"Citation": "Maruyama N, Ishibashi H, Hu W, Morofuji S, Inouye S, Yamaguchi H, Abe S (2006) Suppression of carrageenan- and collagen II-induced inflammation in mice by geranium oil. Mediators Inflamm 2006:62537. https://doi.org/10.1155/MI/2006/62537", "ArticleIdList": ["10.1155/MI/2006/62537", "16951493", "1592600"]}, {"Citation": "Maruyama N, Sekimoto Y, Ishibashi H, Inouye S, Oshima H, Yamaguchi H, Abe S (2005) Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil. J Inflamm (Lond) 2:1. https://doi.org/10.1186/1476-9255-2-1", "ArticleIdList": ["10.1186/1476-9255-2-1", "15813994"]}, {"Citation": "Rai SN, Singh P (2020) Advancement in the modelling and therapeutics of Parkinson\u2019s disease. J Chem Neuroanat 104:101752. https://doi.org/10.1016/j.jchemneu.2020.101752", "ArticleIdList": ["10.1016/j.jchemneu.2020.101752", "31996329"]}, {"Citation": "Wolfe KL, Liu RH (2007) Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J Agric Food Chem 55:8896\u20138907", "ArticleIdList": ["10.1021/jf0715166", "17902627"]}, {"Citation": "Ferrari E, Cardinale A, Picconi B, Gardoni F (2020) From cell lines to pluripotent stem cells for modelling Parkinson\u2019s Disease. J Neurosci Methods 340:108741. https://doi.org/10.1016/j.jneumeth.2020.108741", "ArticleIdList": ["10.1016/j.jneumeth.2020.108741", "32311374"]}, {"Citation": "Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic and clin Pharmacy 7:27\u201331", "ArticleIdList": ["10.4103/0976-0105.177703"]}, {"Citation": "Shan S, Tian L, Fang R (2019) Chlorogenic acid exerts beneficial effects in 6-hydroxydopamine-induced neurotoxicity by inhibition of endoplasmic reticulum stress. Med Sci Monit 25:453\u2013459.", "ArticleIdList": ["10.12659/MSM.911166", "30645211", "6342059"]}, {"Citation": "Palermo G, Giannoni S, Bellini G, Siciliano G, Ceravolo R (2021) Dopamine transporter imaging, current status of a potential biomarker: a comprehensive review. Int J Mol Sci 22. https://doi.org/10.3390/ijms222011234"}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "10", "Day": "5"}, {"Year": "2023", "Month": "11", "Day": "27", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "10", "Day": "11", "Hour": "14", "Minute": "42"}, {"Year": "2023", "Month": "10", "Day": "11", "Hour": "11", "Minute": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37819493", "10.1007/s11130-023-01112-3", "10.1007/s11130-023-01112-3"]}}], "PubmedBookArticle": []}